Janux Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.About JANX
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
CEODavid Campbell
CEODavid Campbell
Employees81
Employees81
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2017
Founded2017
Employees81
Employees81
JANX Key Statistics
Market cap985.82M
Market cap985.82M
Price-Earnings ratio-10.21
Price-Earnings ratio-10.21
Dividend yield—
Dividend yield—
Average volume3.34M
Average volume3.34M
High today$17.24
High today$17.24
Low today$16.30
Low today$16.30
Open price$17.04
Open price$17.04
Volume2.47M
Volume2.47M
52 Week high$71.71
52 Week high$71.71
52 Week low$15.51
52 Week low$15.51
Stock Snapshot
As of today, Janux Therapeutics(JANX) shares are valued at $16.32. The company's market cap stands at 985.82M, with a P/E ratio of -10.21.
During the trading session on 2025-12-04, Janux Therapeutics(JANX) shares reached a daily high of $17.24 and a low of $16.30. At a current price of $16.32, the stock is +0.1% higher than the low and still -5.3% under the high.
Trading activity shows a volume of 2.47M, compared to an average daily volume of 3.34M.
The stock's 52-week range extends from a low of $15.51 to a high of $71.71.
The stock's 52-week range extends from a low of $15.51 to a high of $71.71.
Analyst ratings
95%
of 20 ratingsBuy
95%
Hold
5%
Sell
0%
People also own
Based on the portfolios of people who own JANX. This list is generated using Robinhood data, and it’s not a recommendation.